Immune Function Clinical Trial
Official title:
GCWB1176 8 Weeks, Multi -Tube, Randomized Assignment, Double -Eye, Placebo Control Human Application Test for Evaluating the Effectiveness and Safety of the Immune Function
This human application test was planned to evaluate the effectiveness and safety of immunodefinition compared to the placebo when the GCWB1176 was consumed for those whose white blood cell level was normal or somewhat decreased.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | March 31, 2024 |
Est. primary completion date | January 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. At the time of screening, 19 or 75 years 2. A person with a peripheral blood leukocyte level measured in Visit 1, 3x10^3 cells/µl or more, 8x10^3 cells/µl 3. Those who are more than one of the following standards - Those who had more than twice within one year of visiting 1 year. - {Common cold, acute tonsillitis, acute pharyngitis, acute laryngitis, acute rhinitis, etc. - Those who have stomatitis more than twice within 1 year of visit - Those who had Herpes Zoster infection within 1 year of visit 4. Those with a stress awareness scale (PSS) 16 or more 5. A person who agrees to participate in this human application test before the start of the human test and writes a written consent form Exclusion Criteria: 1. Those who are currently treating drugs due to underlying disease, etc. 2. Hypertension patients (systolic blood pressure 140 mmHg or higher or dichotomous blood pressure 90 mmHg or higher, human application test target 10 minutes stabilized) 3. Patients with diabetes with an fasting blood sugar at least 126 mg/dL or administering urine disease (oral blood sugar, insulin, etc.) 4. Those who are 0.1 UIU/mL or less, or 10 UIU/mL or more 5. Those who have vaccinated vaccines (influenza, corona, shingles that can affect immunity) within 3 months of visiting 1 6. A disease that can affect immune responses such as adult -like and rhinitis 7. AST (GOT) or ALT (GPT) is three times more than the normal upper limit of the embodiment 8. Those who are 1.5 times more than the normal upper limit of Creatinine 9. Those who administered steroids, antibiotics, immunosuppressants, and gastric acid inhibitors within 1 month of visit. 10. Visit 1 person who consumes vitamins, health functional foods that can affect immunity within 2 weeks of visiting 11. A person who has administered or consumed lactic acid bacteria products (4 or more times a week) within 2 weeks of visiting within 2 weeks of visit. 12. Those who complain of severe gastrointestinal symptoms such as heartburn and indigestion 13. Those who are pregnant or have a planning plan for lactation or this human application period 14. Those who have participated in other interventional clinical trials (including human application test) within 8 weeks of visit, or plan to participate in other interventional clinical trials (including human application tests) after the beginning of this human application test 15. Those who are sensitive or allergic to food ingredients for this human application 16. Those who have a BMI (body mass index) of 30 kg/m2 or more 17. A person who consumed alcohol within 1 month (30 days) based on 1 visit (man> 210 g/week, woman> 140 g/week) 18. Those who judge that the test person is inadequate for other reasons |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul St. Mary's Hospital, College of Medicine | Seoul | |
Korea, Republic of | St. Vincent's Hospital, College of Medicine | Suwon-si |
Lead Sponsor | Collaborator |
---|---|
Green Cross Wellbeing |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change amoust of NK Cell Activity | The comparison of the military comparison for the change before and after the intake of NK CELL Activity is analyzed using the PAIRED T-TEST, and the degree of change between the test group and the control at at each point is Two Sample T-Test or Wilcoxon Rank Sum Test It is conducted to evaluate whether there is a statistically significant difference. | week 0, 4 and 8 | |
Secondary | Change amoust of Cytokine analysis (IFN-?, TNF-a, IL-4, IL-10, IL-12) | The comparison of the military in the before and after consumption is analyzed using the PAIIRED T-TEST, and the degree of change between the test group and the control group at each time is performed by performing the two sample T-test or the Wilcoxon Rank Sum Test according to whether the normality is satisfied. Evaluate if there is a significant difference. | week -2, 0, 4 and 8 | |
Secondary | Change amoust of WBC Count analysis | The comparison of the military in the before and after consumption is analyzed using the PAIIRED T-TEST, and the degree of change between the test group and the control group at each time is performed by performing the two sample T-test or the Wilcoxon Rank Sum Test according to whether the normality is satisfied. Evaluate if there is a significant difference. | week -2, 0, 4 and 8 | |
Secondary | Change amoust of FSS Count analysis | The comparison of the military in the before and after consumption is analyzed using the PAIIRED T-TEST, and the degree of change between the test group and the control group at each time is performed by performing the two sample T-test or the Wilcoxon Rank Sum Test according to whether the normality is satisfied. Evaluate if there is a significant difference. | week -2, 0, 4 and 8 | |
Secondary | Change amoust of upper respiratory infection analysis | The comparison of the military in the before and after consumption is analyzed using the PAIIRED T-TEST, and the degree of change between the test group and the control group at each time is performed by performing the two sample T-test or the Wilcoxon Rank Sum Test according to whether the normality is satisfied. Evaluate if there is a significant difference.
If there is a statistically significant difference between the military and clinically significantly significantly significant differences in demographic and lifestyle surveys, ANCOVA can be carried out as a covenant. |
week -2, 0, 4 and 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01545219 -
A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers
|
N/A | |
Completed |
NCT03201068 -
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome
|
N/A | |
Completed |
NCT04960878 -
The Effect of Synbiotics on the Upper Respiratory Tract Infection
|
N/A | |
Completed |
NCT01235390 -
Effects of the Consumption of California Walnuts on Cardiovascular Health
|
Phase 1 | |
Completed |
NCT00858728 -
Effect of Fruit and Vegetable Consumption on Immune Function in the Elderly
|
N/A | |
Recruiting |
NCT06379282 -
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
|
N/A | |
Active, not recruiting |
NCT03442348 -
Omega 3 and Fibre Intervention Study to Improve Metabolic Health
|
N/A | |
Completed |
NCT04486144 -
Impact Nerium Oleander on Immune Function
|
N/A | |
Completed |
NCT05510050 -
Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women
|
N/A | |
Completed |
NCT01586247 -
The Effect of a Prebiotic, Probiotic and Synbiotic on the Gut Microbiota and Immune Response of Older Volunteers (GOS)
|
N/A | |
Completed |
NCT05297825 -
Twins Nutrition Study (TwiNS): Vegan vs. Omnivore
|
N/A | |
Recruiting |
NCT06325969 -
PCOS Patients Immune Status Evaluation
|
||
Recruiting |
NCT06325956 -
PCOS Immune Function Predicts Metformin Efficacy
|
N/A | |
Completed |
NCT03690999 -
The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics
|
N/A | |
Recruiting |
NCT04741308 -
Cognitive Behavior Therapy (CBT) and Psychological Status and Immune Function
|
N/A | |
Recruiting |
NCT05570552 -
1/2- Bangladesh Center for Global Environmental and Occupational Health- Bangladesh
|
N/A | |
Completed |
NCT02261961 -
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
|
N/A | |
Completed |
NCT03330392 -
Evaluation of Efficacy and Safety of AGP on Immune Enhancement
|
N/A | |
Recruiting |
NCT06203249 -
Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
|
||
Completed |
NCT03718988 -
SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial
|
N/A |